Status:
UNKNOWN
The Orange-III Trial: Optimised Recovery With Movicol® Preoperatively Within an Enhanced Recovery Programme
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
Norgine
Conditions:
Liver Diseases
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The aim of this study is to accelerate recovery after liver surgery by enhancing intestinal passage through the preoperative use of Movicol. Hypothesis The use of Movicol® during one week prior to pa...
Detailed Description
Rationale: The routine use of laxatives after liver surgery as part of an Enhanced Recovery After Surgery (ERAS®) programme enhances recovery of gastro-intestinal function and early tolerance of oral...
Eligibility Criteria
Inclusion
- Patients undergoing a partial liver resection
- Able to understand the nature of the study and what will be required of them
- Men and non-pregnant, non-lactating women between age 18-80
- BMI between 18-35
- Patients with ASA I-III
Exclusion
- Inability to give written informed consent
- Patients requiring bile duct reconstruction
- Patients with ASA IV-V
- Superextended hepatectomy
- Underlying symptomatic liver disease such as cirrhosis
- Underlying gastro-intestinal disease such as motility disorders
- Need for procedures additive to partial liver resection
Key Trial Info
Start Date :
July 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01429779
Start Date
July 1 2012
Last Update
April 11 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitatsklinikum Aachen
Aachen, Germany, 52074
2
Maastricht University Hospital
Maastricht, Limburg, Netherlands, 6202 AZ